This inventor holds 3 USPTO granted patents. Top assignee: Yeda Research and Develpment & Co. Ltd. Active years: 2003-2007.
Company Filing History:
Years Active: 2003-2007
Title: Eran Yavin: Innovator in Anti-Inflammatory Peptides
Introduction
Eran Yavin is a prominent inventor based in Rehovot, Israel. He has made significant contributions to the field of biochemistry, particularly in the development of anti-inflammatory peptides. With a total of 3 patents to his name, Yavin's work has the potential to impact the treatment of various chronic inflammatory conditions.
Latest Patents
Yavin's latest patents include innovative peptides derived from C-reactive protein and IL-2. The first patent focuses on anti-inflammatory peptides that inhibit the enzymatic activity of human Leukocyte Elastase and human Cathepsin G. These peptides are designed to treat chronic inflammation conditions such as rheumatoid arthritis, pulmonary emphysema, cystic fibrosis, bronchitis, asthma, and acute respiratory distress syndrome. The second patent involves synthetic anti-inflammatory peptides derived from IL-2, which are useful in managing both acute and chronic inflammation, particularly in autoimmune diseases.
Career Highlights
Eran Yavin is associated with Yeda Research and Development Co. Ltd., where he continues to advance his research in peptide technology. His work is characterized by a strong focus on the therapeutic applications of peptides in inflammatory diseases.
Collaborations
Yavin collaborates with notable colleagues, including Matityahu Fridkin and Rami Hershkoviz, to further enhance the impact of his research.
Conclusion
Eran Yavin's innovative work in the field of anti-inflammatory peptides showcases his commitment to addressing significant health challenges. His contributions have the potential to lead to new treatments for chronic inflammatory conditions, making a lasting impact in the medical field.